Tag Archives: Onglyza
-
-
AstraZeneca Buys Bristol-Myers Squibb Diabetes Interests, Byetta
-
Byetta, Januvia Litigation Being Coordinated Between Federal, State Court
-
No Heart Benefits Or Risks Found in Onglyza or Nesina Diabetes Drugs
-
Onglyza Fails Clinical Trials For Heart Attack, Stroke Prevention
-
Drug Makers to Present New Byetta Data At Diabetes Conference
-
Pancreatic Cancer from Byetta, Januvia, Victoza is Focus of ISMP Report
-
Januvia, Byetta Pancreatic Cancer Risk Review Launched by FDA
-
Onglyza Side Effects Raise Concerns for Consumer Group Public Citizen